Early device partnership for injectable nanobody formulations
Nanogrow develops nanobody biologics with an injectable route among others and is still preclinical, the phase when device choices are cheapest to make. Co-developing a vial-plus-UniPen presentation gives Love Lifesciences a first biologic programme and Nanogrow a low-cost self-administration option.
Evidence from the records
- “Nanobody (sdAb) platform combined with local delivery formulations: topical, nebulized, injectable, oral or via DNA/RNA.”
- “UniPen universal injector pen compatible with standard vials, for self-administration of drugs.”
- If it works
- A letter of intent naming UniPen as the candidate device for one programme, useful for both companies' fundraising.
- First step
- Share UniPen's viscosity/volume envelope with Nanogrow's formulation team.
